Up-regulation of hypoxia-inducible factor-1 alpha and VEGF mRNAs in peritoneal dissemination of patients with gastric cancer

Anticancer Research

Volumn 26, Issue 5 B, 2006, Pages 3849-3853

  Yoshikawa, Takaki ^a   Tsuburaya, Akira ^a   Miyagi, Yohei ^a   Sekiguchi, Hironobu ^a   Kimura, Masayuki ^b   Cho, Haruhiko ^a   Kobayashi, Osamu ^a  

^a KANAGAWA CANCER CENTER   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Hypoxia inducible factor 1; Peritoneal dissemination; Vascular endothelial growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; VASCULOTROPIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PERITONEUM METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR CELL;

BASE SEQUENCE; DNA PRIMERS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; PERITONEAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33750702496     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. The Research Group for Population-based Cancer Registration in Japan: Cancer incidence in Japan, 1985-89: re-estimation based on data from eight population-based cancer registries. Jpn J Clin Oncol 28: 54-67, 1998.
2. Alexander HR, Kelsen DG and Tepper JC: Cancer of the stomach. In: Cancer: Principles and Practice of Oncology. Devita VT, Hellman S, and Rosenberg SA (eds.). Philadelphia, Lippincott-Raven Publishers, pp. 1021-1022, 1997.
3. Yoshikawa T, Tsuburaya A, Kobayashi O et al: Peritoneal cytology in patients with gastric cancer exposed to the serosa - a proposed new classification based on the local and distant cytology. Hepatogastroenterology 50: 1183-1186, 2003.
4. Ajani JA: Chemotherapy for gastric carcinoma: new and old options. Oncology 12: 44-47, 1998.
5. Yonemura Y, Fujimura T, Fushida S et al: Peritonectomy as a treatment modality for patients with peritoneal dissemination from gastric cancer. In: Multimodality Therapy for Gastric Cancer. Nakajima T, Yamaguchi T (eds.). Tokyo, Springer-Verlag. pp. 71-82, 1999.
6. Sugarbaker PH and Yonemura Y: Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 58: 96-107, 2000.
7. Wang GL and Semenza GL: Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270: 1230-1237, 1995.
8. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
9. Huang LE, Arany Z, Livingston DM and Bunn HF: Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271: 32253-32259, 1996.
10. Stroka DM, Burkhardt T, Desbaillets I et al: HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15: 2445-2453, 2001.
11. Nguyen SV and Claycomb WC: Hypoxia regulates the expression of the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes. Biochem Biophys Res Commun 265: 382-386, 1999
12. Lee SH, Wolf PL, Escudero R et al: Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342: 626-633, 2000.
13. Jung F, Palmer LA, Zhou N and Johns RA: Hypoxix regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res 86: 319-325, 2000.
14. Wiener CM, Booth G, Semenza GL: In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 225: 485-488, 1996.
15. Jiang BH, Agani F, Passaniti A and Semenza GL: V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 57: 5328-5335, 1997.
16. Laughner E, Taghavi P, Chiles K, Mahon PC and Semenza GL: HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21: 3995-4004, 2001.
17. Zhong H, Chiles K, Feldser D et al: Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60: 1541-1545, 2000.
18. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
19. Birner P, Schindl M, Obermai A et al: Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 60: 4693-4696, 2000.
20. Kuwai T, Kitadai Y, Tanaka S et al: Expression of hypoxia-inducible factor-1α is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 105: 176-181, 2003.
21. Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G: Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 7: 1661-1668, 2001.
22. Aebersold DM, Burri P, Beer KT et al: Expression of hypoxia-inducible factor-1α: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Clin Cancer Res 61: 2911-2916, 2001.
23. Giatromanolaki A, Koukourakis MI, Sivridis E et al: Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 85: 881-890, 2001.
24. Hui EP, Chan AT, Pezzella F et al: Coexpression of hypoxia-inducible factors 1α and 2α, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res 8: 2595-2604, 2002.
25. Bos R, van der Groep P, Greijer AE et al: Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97: 1573-1581, 2003.
26. Koshikawa N, Iyozumi A, Gassmann M and Takenaga K: Constitutive upregulation of hypoxia-inducible factor-1 alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure. Oncogene 22: 6717-6724, 2003.
27. Zhong H, De Marzo AM, Laughner E et al: Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 59: 5830-5835, 1999.
28. Jones A, Fujiyama C, Blanche C et al: Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines. Clin Cancer Res 7: 1263-1272, 2001.
29. Turner KJ, Moore JW, Jones A et al: Expression of hypoxia-inducible factors in human renal cancer, relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 62: 2957-2961, 2002.
30. Zhong H, Agani F, Baccala AA et al: Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer. Cancer Res 58: 5280-5284, 1998.
31. Matsuyama T, Nakanishi K, Hayashi T et al: Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma. Cancer Sci 96: 176-182, 2005.